Open AccessEfficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia
Author(s) -
Andrew D. Krystal,
Alan Lankford,
H. Heith Durrence,
Elizabeth Ludington,
Philip Jochelson,
Roberta Rogowski,
Thomas Röth
Publication year - 2011
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.5665/sleep.1294
Subject(s) - doxepin , insomnia , primary insomnia , chronic insomnia , medicine , sleep (system call) , anesthesia , physical therapy , psychiatry , sleep disorder , pediatrics , psychology , computer science , operating system
To evaluate the efficacy and safety of doxepin (DXP) 3 mg and 6 mg in adults diagnosed with primary insomnia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom